✦ LIBER ✦

Rejection and tacrolimus conversion therapy in paediatric liver transplantation

✍ Scribed by M. Spada; V. Corno; M. Colledan; A. Segalin; A. Lucianetti; G. Torre; S. Riva; A. Sonzogni; W. Petz; B. Gridelli

Publisher: Springer
Year: 2000
Tongue: English
Weight: 46 KB
Volume: 13
Category: Article
ISSN: 0934-0874
DOI: 10.1007/s001470050357

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of tacrolimus (FK506) i

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients

✍ P. E. Wallemacq; V. Furlan; A. Möller; A. Schäfer; P. Stadler; I. Firdaous; A -M 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 410 KB

Rejection in liver transplantation

✍ Goran B. G. Klintmalm; Joseph R. Nery; Bo S. Husberg; Thomas A. Gonwa; Glenn W. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

GLENN W. TILLERY One hundred four liver transplant recipients were retrospectively reviewed for the incidence of liver allograft rejection, the response to antirejection therapy and the impact of rejection on graft and patient survival. Liver biopsies were performed weekly during episodes of graft d

Conversion from tacrolimus to cyclospori

Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus

✍ Jérôme Dumortier; Sophie Bernard; Yves Bouffard; Olivier Boillot 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Adverse effects associated with calcineurin inhibitors may impact their clinical utility in some patients. This study characterizes the clinical outcomes of liver transplanted (LT) patients who experienced diabetes mellitus (DM) on tacrolimus-based regimen and were converted to cyclosporine-based th

Tacrolimus rescue in liver transplant pa

Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine

✍ Klein, Andrew 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 59 KB

Tacrolimus is an effective immunosuppressant in the rescue of liver allograft patients in whom conventional immunosuppression failed. Efficacy and safety were examined in a multicenter trial of liver transplant recipients converted to tacrolimus because of rejection despite cyclosporine (CyA) therap

Pre- and post-transplant assessment of l

Pre- and post-transplant assessment of liver function in paediatric liver transplantation

✍ M. Burdelski; M. Oellerich; J. Düwel; H. Raith; M. Scheruhn; B. Ringe; B. Rodeck 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 566 KB

Outcomes of acute rejection after interf

Outcomes of acute rejection after interferon therapy in liver transplant recipients

✍ Sammy Saab; Denise Kalmaz; Nupoor A. Gajjar; Jonathan Hiatt; Francisco Durazo; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease in post-liver transplant (LT) recipients. A serious potential adverse effect is acute rejection. We reviewed our experience using interferonbased therapy (interferon or pegylated interferon with or without ribavir